Insider Selling: Teladoc Health Inc (TDOC) Insider Sells 1,285 Shares of Stock

Teladoc Health Inc (NYSE:TDOC) insider Lewis Levy sold 1,285 shares of the firm’s stock in a transaction that occurred on Friday, February 15th. The stock was sold at an average price of $67.21, for a total transaction of $86,364.85. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Lewis Levy also recently made the following trade(s):

  • On Tuesday, January 15th, Lewis Levy sold 1,284 shares of Teladoc Health stock. The stock was sold at an average price of $57.00, for a total transaction of $73,188.00.
  • On Monday, December 17th, Lewis Levy sold 640 shares of Teladoc Health stock. The stock was sold at an average price of $50.00, for a total transaction of $32,000.00.

Shares of NYSE TDOC traded down $0.49 during trading hours on Wednesday, hitting $69.50. 922,908 shares of the stock were exchanged, compared to its average volume of 1,178,547. The company has a current ratio of 8.99, a quick ratio of 8.99 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $4.92 billion, a price-to-earnings ratio of -42.12 and a beta of 1.47. Teladoc Health Inc has a 1-year low of $36.60 and a 1-year high of $89.05.

A number of institutional investors have recently modified their holdings of TDOC. Enlightenment Research LLC acquired a new stake in Teladoc Health in the fourth quarter valued at approximately $25,000. Nikko Asset Management Americas Inc. acquired a new stake in Teladoc Health in the fourth quarter valued at approximately $25,000. Ffcm LLC acquired a new stake in Teladoc Health in the fourth quarter valued at approximately $32,000. Parkside Financial Bank & Trust boosted its position in Teladoc Health by 1,455.0% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,244 shares of the health services provider’s stock valued at $62,000 after buying an additional 1,164 shares in the last quarter. Finally, Penserra Capital Management LLC acquired a new stake in Teladoc Health in the fourth quarter valued at approximately $83,000.

TDOC has been the topic of several recent research reports. Berenberg Bank initiated coverage on shares of Teladoc Health in a report on Thursday, January 31st. They set a “buy” rating and a $80.00 target price on the stock. Zacks Investment Research raised shares of Teladoc Health from a “hold” rating to a “buy” rating and set a $54.00 target price on the stock in a report on Saturday, January 5th. Jefferies Financial Group set a $95.00 price target on shares of Teladoc Health and gave the stock a “buy” rating in a research report on Friday, November 2nd. Chardan Capital increased their price target on shares of Teladoc Health from $98.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, November 2nd. Finally, Cantor Fitzgerald reiterated a “hold” rating and set a $83.00 price target on shares of Teladoc Health in a research report on Monday, January 7th. Four investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. Teladoc Health presently has a consensus rating of “Buy” and a consensus target price of $83.84.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The original version of this piece of content can be accessed at https://www.chaffeybreeze.com/2019/02/20/insider-selling-teladoc-health-inc-tdoc-insider-sells-1285-shares-of-stock.html.

About Teladoc Health

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Recommended Story: Futures Contract

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply